A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer

PURPOSE: This study assessed the safety and tolerability of therapeutic immunization against the human papillomavirus (HPV) viral oncoproteins E6 and E7 in patients with cervical cancer after chemoradiation. METHODS AND MATERIALS: MEDI0457 (INO-3112) is a DNA-based vaccine targeting E6 and E7 of HPV...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Int J Radiat Oncol Biol Phys
Κύριοι συγγραφείς: Hasan, Yasmin, Furtado, Larissa, Tergas, Ana, Lee, Nita, Brooks, Rebecca, McCall, Anne, Golden, Daniel, Jolly, Shruti, Fleming, Gini, Morrow, Matthew, Kraynyak, Kimberly, Sylvester, Albert, Arif, Fauzia, Levin, Matt, Schwartz, David, Boyer, Jean, Skolnik, Jeffrey, Esser, Mark, Kumar, Rakesh, Bagarazzi, Mark, Weichselbaum, Ralph, Spiotto, Michael
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705948/
https://ncbi.nlm.nih.gov/pubmed/32151670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2020.02.031
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια